XML 26 R12.htm IDEA: XBRL DOCUMENT
v3.24.3

EARNINGS (LOSS) PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2024
EARNINGS (LOSS) PER SHARE |
EARNINGS (LOSS) PER SHARE | ​ ​ NOTE 6 – EARNINGS (LOSS) PER SHARE Basic and diluted net earnings (loss) per share attributable to common stockholders were calculated as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Nine Months Ended September 30, | ​ | ​ | Three Months Ended September 30,
(In thousands, except share data) | ​ | ​ | 2024 | ​ | ​ | 2023 | ​ | ​ | 2024 | ​ | 2023
Numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | $ | (3,562) | ​ | $ | 14,356 | ​ | $ | 3,236 | ​ | $ | (1,852)
Add: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Financial expenses of 2024 Notes* | ​ | ​ | ​ | ​ | ​ | (1,610) | ​ | ​ | (503) | ​ | ​ | (1,766)
Net income (loss) for diluted calculation | ​ | $ | (3,562) | ​ | $ | 12,746 | ​ | $ | 2,733 | ​ | $ | (3,618)
Denominator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average shares of Common Stock outstanding for basic calculation | ​ | ​ | 73,301,091 | ​ | ​ | 65,811,506 | ​ | ​ | 73,549,745 | ​ | ​ | 72,281,681
Weighted average dilutive effect of 2024 Notes | ​ | ​ | ​ | ​ | ​ | 13,981,660 | ​ | ​ | 7,667,323 | ​ | ​ | 11,500,998
Weighted average dilutive effect of stock options | ​ | ​ | ​ | ​ | ​ | 1,247,115 | ​ | ​ | - | ​ | ​ | -
Weighted average shares of Common Stock outstanding for diluted calculation | ​ | ​ | 73,301,091 | ​ | ​ | 81,040,281 | ​ | ​ | 81,217,068 | ​ | ​ | 83,782,679
​ * Financial expenses on 2024 Notes consists of add back of financial expense incurred during the period and inclusion of make-whole interest payments that will be incurred upon conversion. Diluted earnings (loss) per share do not include 30,515,287 shares of Common Stock underlying outstanding stock options, warrants and the 2024 Notes for the nine months ended September 30, 2024, and 20,173,438 shares of Common Stock underlying outstanding stock options and warrants for the three months ended September 30, 2024, because the effect would be anti-dilutive. Diluted earnings (loss) per share do not include 19,429,910 and 18,399,260 shares of Common Stock underlying outstanding stock options and warrants of the Company for the three and nine months ended September 30, 2023, respectively, because the effect would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration